Primary |
Hypertension |
77.3% |
Diabetes Mellitus |
5.3% |
Blood Pressure |
1.7% |
Depression |
1.6% |
Blood Pressure Abnormal |
1.4% |
Cardiac Disorder |
1.4% |
Blood Cholesterol |
1.3% |
Pain |
1.3% |
Insomnia |
1.1% |
Sleep Disorder |
1.1% |
Anxiety |
0.9% |
Rheumatoid Arthritis |
0.9% |
Anticoagulant Therapy |
0.8% |
Hypertensive Crisis |
0.8% |
Intraocular Pressure Test Abnormal |
0.6% |
Migraine |
0.6% |
Blood Cholesterol Increased |
0.5% |
Chronic Obstructive Pulmonary Disease |
0.5% |
Essential Hypertension |
0.5% |
Eye Disorder |
0.5% |
|
Death |
18.9% |
Wrong Technique In Drug Usage Process |
8.2% |
Blood Pressure Increased |
7.8% |
Oedema Peripheral |
6.6% |
Hypertension |
5.8% |
Infarction |
4.9% |
Renal Failure |
4.9% |
Cerebrovascular Accident |
4.5% |
Feeling Abnormal |
4.5% |
Hypotension |
4.5% |
Myocardial Infarction |
4.1% |
Visual Impairment |
3.7% |
Blood Pressure Inadequately Controlled |
3.3% |
Sudden Death |
3.3% |
Malaise |
2.9% |
Pain In Extremity |
2.9% |
Fatigue |
2.5% |
Neoplasm Malignant |
2.5% |
Dyspnoea |
2.1% |
Headache |
2.1% |
|
Secondary |
Hypertension |
61.2% |
Diabetes Mellitus |
13.0% |
Rheumatoid Arthritis |
2.8% |
Depression |
2.6% |
Hyperlipidaemia |
1.9% |
Pain |
1.9% |
Product Used For Unknown Indication |
1.9% |
Cardiac Disorder |
1.3% |
Osteoporosis |
1.3% |
Arthralgia |
1.1% |
Coronary Artery Disease |
1.1% |
Essential Hypertension |
1.1% |
Gastritis |
1.1% |
Hyperuricaemia |
1.1% |
Platelet Aggregation Inhibition |
1.1% |
Sleep Disorder |
1.1% |
Weight Control |
1.1% |
Abdominal Discomfort |
0.9% |
Anxiety |
0.9% |
Arthritis |
0.9% |
|
Wrong Technique In Drug Usage Process |
22.3% |
Oedema Peripheral |
10.7% |
Angina Pectoris |
6.8% |
Visual Impairment |
6.8% |
Blood Pressure Systolic Increased |
3.9% |
Blood Triglycerides Increased |
3.9% |
Cardiac Valve Rupture |
3.9% |
Dyspnoea |
3.9% |
Hypertension |
3.9% |
Paraesthesia Oral |
3.9% |
Vertigo |
3.9% |
Blood Glucose Increased |
2.9% |
Blood Pressure Decreased |
2.9% |
Blood Pressure Increased |
2.9% |
Drug Ineffective |
2.9% |
Hypotonia |
2.9% |
Malaise |
2.9% |
Myocardial Infarction |
2.9% |
Renal Failure |
2.9% |
Sensory Disturbance |
2.9% |
|
Concomitant |
Product Used For Unknown Indication |
59.7% |
Hypertension |
10.9% |
Asthma |
2.9% |
Chest Pain |
2.5% |
Diabetes Mellitus |
2.5% |
Hypertensive Heart Disease |
2.5% |
Gastrooesophageal Reflux Disease |
2.4% |
Hyperlipidaemia |
2.2% |
Psoriasis |
1.7% |
Blood Pressure |
1.6% |
Rheumatoid Arthritis |
1.6% |
Hyperparathyroidism Secondary |
1.5% |
Psoriatic Arthropathy |
1.4% |
Blood Cholesterol Increased |
1.3% |
Multiple Allergies |
1.3% |
Type 2 Diabetes Mellitus |
1.3% |
Nasal Congestion |
1.0% |
Pain |
0.9% |
Atrial Fibrillation |
0.5% |
Cardiac Disorder |
0.5% |
|
Tooth Disorder |
8.3% |
Drug Ineffective |
6.3% |
Flushing |
6.3% |
Hyperkalaemia |
6.3% |
Injection Site Swelling |
6.3% |
Oedema |
6.3% |
Osteoarthritis |
6.3% |
Blood Pressure Increased |
4.2% |
Cerebrovascular Accident |
4.2% |
Death |
4.2% |
Dilatation Atrial |
4.2% |
Diverticulitis |
4.2% |
Myalgia |
4.2% |
Pain In Extremity |
4.2% |
Pericardial Effusion |
4.2% |
Psoriasis |
4.2% |
Renal Failure |
4.2% |
Sinus Tachycardia |
4.2% |
Tonsillitis |
4.2% |
Urine Output Decreased |
4.2% |
|
Interacting |
Hypertension |
28.6% |
Depression |
9.5% |
Parkinson's Disease |
9.5% |
Prinzmetal Angina |
9.5% |
Sciatica |
9.5% |
Soft Tissue Infection |
9.5% |
Type 2 Diabetes Mellitus |
9.5% |
Epilepsy |
4.8% |
Hypercholesterolaemia |
4.8% |
Hypothyroidism |
4.8% |
|
Drug Interaction |
25.0% |
Gastrointestinal Disorder |
25.0% |
Pulmonary Oedema |
25.0% |
Vomiting |
25.0% |
|